S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
Warren Buffett's company dumps another 5 million shares of printer maker HP
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Beat the Yields on near 5% Treasuries, plus Upside
Low PE Growth Stocks: Unlocking Investment Opportunities
Would Buffett Approve of This Growth Strategy? (Ad)
Why Ralph Lauren Should Be On Your Holiday Wishlist
Stock market today: Wall Street futures inch higher as bond yields stabilize, oil prices slide
Would Buffett Approve of This Growth Strategy? (Ad)
3 Reliable Growing Dividends Near Rock-Bottom Prices
5 Short Squeeze Candidates With Catalysts For Rebounds
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
Warren Buffett's company dumps another 5 million shares of printer maker HP
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Beat the Yields on near 5% Treasuries, plus Upside
Low PE Growth Stocks: Unlocking Investment Opportunities
Would Buffett Approve of This Growth Strategy? (Ad)
Why Ralph Lauren Should Be On Your Holiday Wishlist
Stock market today: Wall Street futures inch higher as bond yields stabilize, oil prices slide
Would Buffett Approve of This Growth Strategy? (Ad)
3 Reliable Growing Dividends Near Rock-Bottom Prices
5 Short Squeeze Candidates With Catalysts For Rebounds
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
Warren Buffett's company dumps another 5 million shares of printer maker HP
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Beat the Yields on near 5% Treasuries, plus Upside
Low PE Growth Stocks: Unlocking Investment Opportunities
Would Buffett Approve of This Growth Strategy? (Ad)
Why Ralph Lauren Should Be On Your Holiday Wishlist
Stock market today: Wall Street futures inch higher as bond yields stabilize, oil prices slide
Would Buffett Approve of This Growth Strategy? (Ad)
3 Reliable Growing Dividends Near Rock-Bottom Prices
5 Short Squeeze Candidates With Catalysts For Rebounds
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
Warren Buffett's company dumps another 5 million shares of printer maker HP
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Beat the Yields on near 5% Treasuries, plus Upside
Low PE Growth Stocks: Unlocking Investment Opportunities
Would Buffett Approve of This Growth Strategy? (Ad)
Why Ralph Lauren Should Be On Your Holiday Wishlist
Stock market today: Wall Street futures inch higher as bond yields stabilize, oil prices slide
Would Buffett Approve of This Growth Strategy? (Ad)
3 Reliable Growing Dividends Near Rock-Bottom Prices
5 Short Squeeze Candidates With Catalysts For Rebounds
NYSE:BAX

Baxter International (BAX) Stock Forecast, Price & News

$36.80
-0.55 (-1.47%)
(As of 10/3/2023 ET)
Compare
Today's Range
$36.66
$37.39
50-Day Range
$36.80
$48.95
52-Week Range
$36.66
$58.23
Volume
5.69 million shs
Average Volume
3.99 million shs
Market Capitalization
$18.64 billion
P/E Ratio
N/A
Dividend Yield
3.15%
Price Target
$50.80

Baxter International MarketRank™ Forecast

Analyst Rating
Hold
2.21 Rating Score
Upside/​Downside
38.0% Upside
$50.80 Price Target
Short Interest
Healthy
1.46% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-1.95
Upright™ Environmental Score
News Sentiment
0.21mentions of Baxter International in the last 14 days
Based on 12 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
21.18%
From $2.55 to $3.09 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.66 out of 5 stars

Medical Sector

109th out of 965 stocks

Surgical & Medical Instruments Industry

20th out of 99 stocks


BAX stock logo

About Baxter International (NYSE:BAX) Stock

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules; and a collaborative research agreement with Miromatrix Medical Inc. to develop treatments for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is based in Deerfield, Illinois.

BAX Price History

BAX Stock News Headlines

12 Best Places to Retire in Dominican Republic
The Strategic Gold Play You Haven't Heard About
Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure.
Baxter Appoints Joel Grade As CFO
Baxter Appoints Joel Grade Chief Financial Officer
Baxter International (NYSE:BAX) PT Lowered to $41.00
Illinois firm laying off 459 in Alabama
The Strategic Gold Play You Haven't Heard About
Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure.
See More Headlines
Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Company Calendar

Last Earnings
7/27/2023
Ex-Dividend for 10/2 Dividend
8/31/2023
Dividend Payable
10/02/2023
Today
10/04/2023
Next Earnings (Confirmed)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
07181310
Employees
60,000
Year Founded
1931

Price Target and Rating

Average Stock Price Forecast
$50.80
High Stock Price Forecast
$62.00
Low Stock Price Forecast
$41.00
Forecasted Upside/Downside
+38.0%
Consensus Rating
Hold
Rating Score (0-4)
2.21
Research Coverage
14 Analysts

Profitability

Net Income
$-2,433,000,000.00
Pretax Margin
-18.51%

Debt

Sales & Book Value

Annual Sales
$15.11 billion
Cash Flow
$12.23 per share
Book Value
$11.69 per share

Miscellaneous

Free Float
505,139,000
Market Cap
$18.64 billion
Optionable
Optionable
Beta
0.62

Social Links

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Jose E. Almeida (Age 61)
    Chairman, Pres & CEO
    Comp: $2.1M
  • Mr. David S. Rosenbloom (Age 63)
    Exec. VP & Gen. Counsel
    Comp: $776.51k
  • Mr. Brian C. StevensMr. Brian C. Stevens (Age 48)
    Sr. VP, Interim CFO, Chief Accounting Officer & Controller
  • Mr. Talvis P. Love (Age 55)
    Sr. VP & Chief Information Officer
  • Ms. Tobi Karchmer M.D.
    M.S., Sr. VP and Chief Medical & Scientific Officer
  • Ms. Clare Trachtman
    VP of Investor Relations
  • Ms. Stacey Eisen
    Sr. VP of Global Communications
  • Ms. Jeanne K. Mason Ph.D.Ms. Jeanne K. Mason Ph.D. (Age 67)
    ?Exec. VP & Chief HR Officer
  • Mr. James W. Borzi (Age 60)
    Exec. VP & Chief Supply Chain Officer
  • J. J. Markee
    Chief Information Security Officer













BAX Stock - Frequently Asked Questions

Should I buy or sell Baxter International stock right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 1 sell rating, 9 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" BAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAX, but not buy additional shares or sell existing shares.
View BAX analyst ratings
or view top-rated stocks.

What is Baxter International's stock price forecast for 2023?

14 brokers have issued twelve-month price targets for Baxter International's shares. Their BAX share price forecasts range from $41.00 to $62.00. On average, they anticipate the company's stock price to reach $50.80 in the next twelve months. This suggests a possible upside of 38.0% from the stock's current price.
View analysts price targets for BAX
or view top-rated stocks among Wall Street analysts.

How have BAX shares performed in 2023?

Baxter International's stock was trading at $50.97 at the beginning of 2023. Since then, BAX shares have decreased by 27.8% and is now trading at $36.80.
View the best growth stocks for 2023 here
.

Are investors shorting Baxter International?

Baxter International saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 7,170,000 shares, an increase of 10.8% from the August 15th total of 6,470,000 shares. Based on an average daily trading volume, of 4,580,000 shares, the short-interest ratio is presently 1.6 days. Approximately 1.4% of the company's stock are short sold.
View Baxter International's Short Interest
.

When is Baxter International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our BAX earnings forecast
.

How can I listen to Baxter International's earnings call?

Baxter International will be holding an earnings conference call on Thursday, November 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) announced its earnings results on Thursday, July, 27th. The medical instruments supplier reported $0.55 earnings per share for the quarter, missing analysts' consensus estimates of $0.59 by $0.04. The medical instruments supplier had revenue of $3.71 billion for the quarter, compared to analysts' expectations of $3.79 billion. Baxter International had a positive trailing twelve-month return on equity of 24.94% and a negative net margin of 19.00%.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International declared a quarterly dividend on Tuesday, July 18th. Stockholders of record on Friday, September 1st will be paid a dividend of $0.29 per share on Monday, October 2nd. This represents a $1.16 dividend on an annualized basis and a yield of 3.15%. The ex-dividend date is Thursday, August 31st.
Read our dividend analysis for BAX
.

Is Baxter International a good dividend stock?

Baxter International (NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 3.07%.
Read our dividend analysis for BAX.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International issued an update on its third quarter 2023 earnings guidance on Thursday, July, 27th. The company provided EPS guidance of $0.65-$0.67 for the period, compared to the consensus estimate of $0.80. The company issued revenue guidance of -.

What is José (Joe) Almeida's approval rating as Baxter International's CEO?

506 employees have rated Baxter International Chief Executive Officer José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

How do I buy shares of Baxter International?

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $36.80.

How much money does Baxter International make?

Baxter International (NYSE:BAX) has a market capitalization of $18.64 billion and generates $15.11 billion in revenue each year. The medical instruments supplier earns $-2,433,000,000.00 in net income (profit) each year or ($5.66) on an earnings per share basis.

How many employees does Baxter International have?

The company employs 60,000 workers across the globe.

Does Baxter International have any subsidiaries?
The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..
Read More
How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The official website for the company is www.baxter.com. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at global_corp_investor_relations@baxter.com, or via fax at 224-948-1813.

This page (NYSE:BAX) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -